MCOLN1/TRPML1 in the lysosome: a promising target for autophagy modulation in diverse diseases
- PMID: 38522082
- PMCID: PMC11262240
- DOI: 10.1080/15548627.2024.2333715
MCOLN1/TRPML1 in the lysosome: a promising target for autophagy modulation in diverse diseases
Abstract
MCOLN1/TRPML1 is a nonselective cationic channel specifically localized to the late endosome and lysosome. With its property of mediating the release of several divalent cations such as Ca2+, Zn2+ and Fe2+ from the lysosome to the cytosol, MCOLN1 plays a pivotal role in regulating a variety of cellular events including endocytosis, exocytosis, lysosomal biogenesis, lysosome reformation, and especially in Macroautophagy/autophagy. Autophagy is a highly conserved catabolic process that maintains cytoplasmic integrity by removing superfluous proteins and damaged organelles. Acting as the terminal compartments, lysosomes are crucial for the completion of the autophagy process. This review delves into the emerging role of MCOLN1 in controlling the autophagic process by regulating lysosomal ionic homeostasis, thereby governing the fundamental functions of lysosomes. Furthermore, this review summarizes the physiological relevance as well as molecular mechanisms through which MCOLN1 orchestrates autophagy, consequently influencing mitochondria turnover, cell apoptosis and migration. In addition, we have illustrated the implications of MCOLN1-regulated autophagy in the pathological process of cancer and myocardial ischemia-reperfusion (I/R) injury. In summary, given the involvement of MCOLN1-mediated autophagy in the pathogenesis of cancer and myocardial I/R injury, targeting MCOLN1 May provide clues for developing new therapeutic strategies for the treatment of these diseases. Exploring the regulation of MCOLN1-mediated autophagy in diverse diseases contexts will surely broaden our understanding of this pathway and offer its potential as a promising drug target.Abbreviation: CCCP:carbonyl cyanide3-chlorophenylhydrazone; CQ:chloroquine; HCQ: hydroxychloroquine;I/R: ischemia-reperfusion; MAP1LC3/LC3:microtubule associated protein 1 light chain 3; MCOLN1/TRPML1:mucolipin TRP cation channel 1; MLIV: mucolipidosis type IV; MTORC1:MTOR complex 1; ROS: reactive oxygenspecies; SQSTM1/p62: sequestosome 1.
Keywords: Autophagy inhibition; MCOLN1; cardiomyocyte death; mitochondria turnover; tumorigenesis.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
MCOLN1/TRPML1 finely controls oncogenic autophagy in cancer by mediating zinc influx.Autophagy. 2021 Dec;17(12):4401-4422. doi: 10.1080/15548627.2021.1917132. Epub 2021 Apr 23. Autophagy. 2021. PMID: 33890549 Free PMC article.
-
Targeting MCOLN1/TRPML1 channels to protect against ischemia-reperfusion injury by restoring the inhibited autophagic flux in cardiomyocytes.Autophagy. 2022 Dec;18(12):3053-3055. doi: 10.1080/15548627.2022.2072657. Epub 2022 May 6. Autophagy. 2022. PMID: 35491864 Free PMC article.
-
Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway.Autophagy. 2022 Aug;18(8):1932-1954. doi: 10.1080/15548627.2021.2008752. Epub 2021 Dec 8. Autophagy. 2022. PMID: 34878954 Free PMC article.
-
TRPML1: The Ca(2+)retaker of the lysosome.Cell Calcium. 2018 Jan;69:112-121. doi: 10.1016/j.ceca.2017.06.006. Epub 2017 Jun 24. Cell Calcium. 2018. PMID: 28689729 Review.
-
MCOLN/TRPML channels in the regulation of MTORC1 and autophagy.Autophagy. 2024 May;20(5):1203-1204. doi: 10.1080/15548627.2023.2300922. Epub 2024 Jan 5. Autophagy. 2024. PMID: 38180017 Free PMC article. Review.
Cited by
-
TRPML3‑mediated lysosomal Ca2+ release enhances drug sequestration and biogenesis, promoting osimertinib resistance in non‑small cell lung cancer.Oncol Rep. 2025 Sep;54(3):113. doi: 10.3892/or.2025.8946. Epub 2025 Jul 19. Oncol Rep. 2025. PMID: 40682834 Free PMC article.
-
Novel strategies targeting mitochondria-lysosome contact sites for the treatment of neurological diseases.Front Mol Neurosci. 2025 Jan 14;17:1527013. doi: 10.3389/fnmol.2024.1527013. eCollection 2024. Front Mol Neurosci. 2025. PMID: 39877141 Free PMC article. Review.
-
Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease.Front Cardiovasc Med. 2025 Jul 15;12:1620669. doi: 10.3389/fcvm.2025.1620669. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40734978 Free PMC article. Review.
-
Lysosomes finely control macrophage inflammatory function via regulating the release of lysosomal Fe2+ through TRPML1 channel.Nat Commun. 2025 Jan 24;16(1):985. doi: 10.1038/s41467-025-56403-x. Nat Commun. 2025. PMID: 39856099 Free PMC article.
-
Lysosomal TFEB-TRPML1 Axis in Astrocytes Modulates Depressive-like Behaviors.Adv Sci (Weinh). 2024 Nov;11(41):e2403389. doi: 10.1002/advs.202403389. Epub 2024 Sep 12. Adv Sci (Weinh). 2024. PMID: 39264289 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous